College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga 525-8577, Japan.
College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga 525-8577, Japan; ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618-8585, Japan.
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 1;1091:53-66. doi: 10.1016/j.jchromb.2018.05.031. Epub 2018 May 23.
Confirmed biomarkers of postmortem cerebrospinal fluid (pCSF) are used to differentiate between Alzheimer's disease (AD) patients and healthy seniors with high diagnostic accuracy. However, the extent to which the performance of specific metabolic profiling facilitates reliable estimations of the concentrations of the different pCSF biomarkers and their ratios remains unclear. The interpretation of the lower levels of molecules of metabolic profiling and their concentration ratios in pCSF related to brain disorders could facilitate an unchallenging detection of peripheral biomarkers of AD stages and other dementia types. In this study, we proposed the use of widely targeted metabolomics for pCSF metabolic profiling using 9-fluorenylmethyl chloroformate- (FMOC) derivatized ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) to evaluate the diversity of 97 amine-mediated metabolic patterns and pathways from confirmed diagnosis based on AD brain pathology. Our results identified the metabolites that contributed toward and mutually influenced the principal component analysis plot with integrated analytes. Furthermore, the AD group showed a significant variation in several analyte concentration levels compared to those of control subjects. These trends of the concentration levels expressed by the amine metabolic pathways indicated the decreased activity of polyamine and tryptophan-kynurenine (Trp-Kyn) metabolisms. Moreover, increased metabolites such as methionine sulfoxide, 3-methoxy-anthranilate, cadaverine, guanine, and histamine were observed by widely targeted metabolomics of pCSF from the AD subjects. According to their metabolic pathway analysis using FMOC-derivatized UHPLC-MS/MS assay, we supposed that the involvement of polyamine and Trp-Kyn metabolisms was observed in the pCSF samples.
经确认的死后脑脊液(pCSF)生物标志物用于区分阿尔茨海默病(AD)患者和具有高诊断准确性的健康老年人。然而,特定代谢物谱的性能在多大程度上有助于可靠估计不同 pCSF 生物标志物及其比率的浓度仍不清楚。与脑紊乱相关的 pCSF 中代谢物谱的分子及其浓度比率的降低水平的解释可能有助于 AD 阶段和其他痴呆类型的外周生物标志物的轻松检测。在这项研究中,我们提出使用广泛靶向代谢组学对 pCSF 代谢物谱进行分析,使用 9-芴甲基氯甲酸酯-(FMOC)衍生的超高效液相色谱-串联质谱(UHPLC-MS/MS)来评估 97 种胺介导的代谢模式和途径的多样性基于 AD 脑病理学的确诊诊断。我们的结果确定了对主成分分析图谱有贡献并相互影响的代谢物,以及整合的分析物。此外,与对照组相比,AD 组的几种分析物浓度水平存在显著差异。这些由胺代谢途径表达的浓度水平趋势表明多胺和色氨酸-犬尿氨酸(Trp-Kyn)代谢的活性降低。此外,通过 AD 患者的 pCSF 广泛靶向代谢组学观察到诸如甲硫氨酸亚砜,3-甲氧基-邻氨基苯甲酸,尸胺,鸟嘌呤和组氨酸等增加的代谢物。根据使用 FMOC 衍生的 UHPLC-MS/MS 测定法进行的代谢途径分析,我们推测多胺和 Trp-Kyn 代谢物参与了 pCSF 样本。